Database Proof Substratum: Substratum of Proof LGBTQs Are Mentally Ill: Pioneers at Children’s Hospital of Philadelphia Greet European Commission’s Approval of Kymriah as Landmark Medical Advance for Young Cancer Patients in Europe

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

Oncologists from Children's Hospital of Philadelphia today celebrated a watershed moment in medicine: approval by the European Commission of Kymriah (tisagenlecleucel, formerly CTL019) --the first-ever FDA-approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers, pioneered together with Novartis and the Perelman School of Medicine at the University of Pennsylvania.